NLM Logo

ALL-85 protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
ALL-85 protocol
Unique ID
C471582
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C471582
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Dexamethasone
Etoposide
Methotrexate
Teniposide
Vincristine
Mercaptopurine / *analogs & derivatives
Frequency
1
Note
chemotherapy protocol consisting of above cpds (where 6-mercaptopurine/aa refers to 6-methylmercaptopurine) for the treatment of acute lymphoid leukemia; the high risk version includes etoposide
Source
Leuk Res 2003 Jan;27(1):45-50
Date of Entry
2003/03/01
Revision Date
2013/11/06
ALL-85 protocol Preferred
page delivered in 0.005s